Benchmark Reiterates Hold on VolitionRX
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bruce Jackson has reiterated a Hold rating on VolitionRX (AMEX:VNRX).

August 16, 2024 | 1:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Benchmark analyst Bruce Jackson has reiterated a Hold rating on VolitionRX (AMEX:VNRX).
The reiteration of a Hold rating suggests that the analyst does not see significant upside or downside in the short term. This is likely to result in a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100